Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Cancer Cells can Communicate Over Longer Distances Within the Body

By Sandy Evangelista, Ecole Polytechnique Federale de Lausanne | May 10, 2019

Credit: Ecole Polytechnique Federale de Lausanne

EPFL researchers have discovered that cancer cells use exosomes to communicate with each other and send information through the bloodstream. This breakthrough opens up new possibilities for the use of cancer immunotherapy techniques.

“It was a huge surprise, we didn’t expect to find so many melanoma cancer cell markers in blood exosomes,” explains Hubert Girault, who heads up the Laboratory of Physical and Analytical Electrochemistry at EPFL Valais Wallis. Professor Girault and his team made the discovery almost by accident. Their findings, which have been published in the journal Chem, offer insight into how cancer cells communicate with each other and send information around the body.

All biological cells excrete exosomes, microscopic spheres or vesicles that are less than 100 nanometers in size and contain a wealth of information in the form of nucleic acids, proteins and markers. Exosomes perform cell-to-cell signaling, conveying information between cells. Under the supervision of Senior Scientist Dr. Horst Pick, EPFL doctoral assistant Yingdi Zhu used cell culture and mass spectrometry to isolate melanoma cancer cell exosomes. She was able to identify cancer cell markers in exosomes for each stage of melanoma growth.

When analyzing the blood exosomes of melanoma patients, the researchers were surprised to discover large quantities of cancer cell markers. The blood collects and transports all the exosomes that the body generates. While healthy cells usually produce exosomes in small quantities, cancer cells produce many more. But it was previously thought that these would be so diluted in the blood that they would be hard to detect. For Professor Girault, the discovery of large quantities of cancer cell markers in blood exosomes raises numerous questions about signaling between cancer cells, which until now were not thought to communicate over longer distances within the body.

Indicating the stage of a tumor

This intercellular communication is thought to facilitate the spread of cancer cells by preparing tissue for metastasis. Professor Girault’s team also found that the markers offer an indication of how developed the tumor is. Being able to identify these markers means that a simple blood test, rather than a biopsy, could provide information about the presence of a tumor and its stage and perhaps even be used to predict therapeutic responses. This would help to speed up the diagnostic process. At the Ludwig Institute for Cancer Research at UNIL/Department of Oncology UNIL CHUV, Dr. Ping-Chih Ho is exploring the exosome trail in order to develop new approaches to vaccine design and cancer immunotherapy. He was also very surprised by the findings: “I didn’t think it would be possible to use exosomes to detect melanoma incidence so accurately. This breakthrough opens up new possibilities for the use of the cancer immunotherapy technique that I’m currently developing with Professor Girault.”


Filed Under: Oncology

 

Related Articles Read More >

Roche in Drug Discovery & Development Pharma 50
Roche’s bispecific antibody Lunsumio wins priority review from FDA for non-Hodgkin lymphoma
AstraZeneca
AstraZeneca to scoop up biotech TeneoTwo for up to $1.27 billion
Novartis in the Pharma 50
Novartis announces tislelizumab helped extend median overall survival in first-line advanced esophageal cancer 
Johnson & Johnson Janssen pharmaceutical business in the Pharma 50
Janssen gets positive CHMP opinion for Imbruvica for adults with untreated chronic lymphocytic leukemia

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50